ArticleEnvironmental health and preventive medicine2024
Association of mixed polycyclic aromatic hydrocarbons exposure with cardiovascular disease and the mediating role of inflammatory indices in US adults.
Article in Environmental health and preventive medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A Perfect Storm of Pollutants: Environmental Mixtures in the Pathogenesis of Atherosclerosis.International journal of molecular sciences · 2026Review
- Review
- Association between combined exposure to underground air pollutants and hypertension in coal miners: a cross-sectional study.BMC public health · 2025Article
- Association Between Urinary Metals and Polycyclic Aromatic Hydrocarbon Levels and Cardiovascular Disease Among Adult Americans: Data from NHANES 2011 to 2016.Cardiovascular toxicology · 2025Article
- Epigenetic age acceleration mediates the association between low-grade systemic inflammation and cardiovascular diseases: insight from the NHANES 1999-2002.Clinical epigenetics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular disease (CVD) is the leading cause of death worldwide. Few studies have investigated the effects of mixed polycyclic aromatic hydrocarbon (PAH) exposure on CVD prevalence. We aimed to evaluate the association between mixed PAHs exposure and CVD and determine the extent to which these links are mediated by inflammatory indices.
methodsWe used National Health and Nutrition Examination Survey (NHANES) data from 2003 to 2016. Adults with a diagnosis of CVD and seven monohydroxylated PAH metabolites (OH-PAHs) in their urine samples were included. Multivariate logistic regression and Bayesian kernel machine regression (BKMR) models were used to estimate the association between single and mixed PAHs exposure and CVD. Mediation analysis was used to evaluate the mediating effect of inflammatory indices on the association between PAHs mixtures and CVD.
resultsHere, 9136 individuals were included and 10.5% had CVD. Multivariate logistic regression analysis with all the OH-PAHs included that 2-hydroxyfluorene was found positively associated with increased odds of CVD. The BKMR analysis revealed that the overall effect of the seven PAH mixtures was positively associated with CVD. The univariate exposure-response function showed that 2-hydroxyfluorene was positively associated with CVD. Moreover, mediation analysis demonstrated that neutrophil-to-lymphocyte ratio and systemic immune inflammation index mediated the association between PAHs and CVD.
conclusionsOur findings highlight the complexity of the association between mixed PAHs exposure and CVD. At the same time, our study provides insight into the potential mechanisms of inflammation as a mediator between exposure to PAH mixtures and CVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.